The Manufacturers Life Insurance Company Invests $10.93 Million in SPDR S&P Biotech ETF $XBI

The Manufacturers Life Insurance Company purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 69,047 shares of the exchange traded fund’s stock, valued at approximately $10,927,000. The Manufacturers Life Insurance Company owned approximately 0.11% of SPDR S&P Biotech ETF as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Sequoia Financial Advisors LLC lifted its holdings in SPDR S&P Biotech ETF by 27.7% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,523 shares of the exchange traded fund’s stock worth $557,000 after purchasing an additional 765 shares in the last quarter. Tidal Investments LLC grew its holdings in SPDR S&P Biotech ETF by 1,771.5% during the 2nd quarter. Tidal Investments LLC now owns 109,331 shares of the exchange traded fund’s stock valued at $17,302,000 after buying an additional 103,489 shares in the last quarter. IPG Investment Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 93.3% during the 2nd quarter. IPG Investment Advisors LLC now owns 5,908 shares of the exchange traded fund’s stock valued at $935,000 after buying an additional 2,852 shares in the last quarter. Maven Securities LTD bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at about $3,028,000. Finally, RFG Advisory LLC bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at about $1,118,000.

SPDR S&P Biotech ETF Trading Down 0.4%

Shares of SPDR S&P Biotech ETF stock opened at $156.20 on Friday. SPDR S&P Biotech ETF has a 12-month low of $92.64 and a 12-month high of $169.89. The company has a market cap of $10.20 billion, a price-to-earnings ratio of 11.47 and a beta of 0.84. The company’s 50-day moving average price is $158.26 and its 200-day moving average price is $141.72.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.